D

Develo

Pediatric EMR and practice management platform

Overview

Develo provides a subscription-based software platform tailored for independent pediatric practices. It combines electronic medical records (EMR) designed by pediatricians with a set of integrated tools such as digital intake forms, e-fax integration, and automated document tagging to streamline administrative and clinical tasks in pediatric clinics. The product works by offering a connected, pediatric-specific suite that practices use to manage patient information, appointments, and workflows through a centralized system, improving team productivity and family engagement. Develo differentiates itself from competitors by focusing exclusively on pediatric care, ensuring the software is built with pediatricians’ input and addressing the unique needs of young patients rather than using generic EMR systems. Its goal is to raise operational efficiency, enhance care quality, and increase loyalty and satisfaction among families seen in independent pediatric practices.

Work here?Claim your company

About Develo

Simplify's Rating
Why Develo is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Enterprise SoftwareHealthcare

Company Size

11-50

Company Stage

Series A

Total Funding

$16.5M

Headquarters

Los Angeles, CA

Founded

2020

Get referred to Develo

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Develo raised $14 million on May 11, 2026, led by Blueprint Equity.
  • By November 2026, hundreds of pediatric providers across more than 24 states use it.
  • Its ONC-certified platform targets independent pediatric practices with bundled migration, training, and support.

What critics are saying

  • PCC won Best in KLAS 2026; Develo lacks comparable third-party validation and review depth.
  • Develo's pediatric-only scope excludes other specialties, limiting expansion beyond one narrow wedge.
  • Incumbents like NextGen and Greenway can copy pediatric features before Develo reaches scale.

What makes Develo unique

  • Develo, founded 2022, is pediatrics-only, unlike Greenway, NextGen, and Tebra.
  • Its AI-native stack bundles EMR, billing, family engagement, e-fax filing, and reporting.
  • Weekly minor releases and biweekly major releases signal unusually fast pediatric workflow iteration.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$16.5M

Meets

Industry Average

Funded Over

2 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Meet Average

Industry standards

$15M
$8.2M
$14M
$15M
$30M

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Unlimited Paid Time Off
  • Flexible Work Hours
  • Remote Work Options
  • Hybrid Work Options
  • Company Equity

Company News

EIN Presswire
May 11th, 2026
Develo raises $14M for AI-native paediatric operating system beyond traditional EMRs

Develo, an AI-native operating system for pediatrics, has raised $14 million in a funding round led by Blueprint Equity, with participation from Villain Capital, Z21 Ventures and Bienville Capital. Angel investors include executives from CentralReach, Community CareLink and former CEOs of Allscripts and Cerner. Founded in 2022, Develo addresses the fragmented technology landscape in paediatric care, which accounts for over 450 million annual visits in the US. The platform unifies clinical, billing and family engagement workflows, moving beyond traditional electronic medical record systems built for adult care and retrofitted for paediatrics. The company has deployed its AI-first operating system for hundreds of paediatric providers across more than two dozen states. The funding will accelerate growth in research and development and customer success initiatives.

U.S. Securities and Exchange Commission
Oct 10th, 2023
SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.

Recently Posted Jobs

Sign up to get curated job recommendations

Develo is Hiring for 1 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs